Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations, 201816-02-2023
16-02-2023
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Q3 FY23 Earnings Conference Call Transcript enclosed14-02-2023
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations, 201813-02-2023
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Change in Management
Intimation of appointment of Chief Executive Officer in terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.09-02-2023
Windlas Biotech Ltd - 543329 - Audio Recording Of Earnings Call
Audio Recording of Earnings Call09-02-2023
Windlas Biotech Ltd - 543329 - Statement Of Deviation
In terms of SEBI Circular No. CIR/CFD/CMD1/162/2019 dated December 24, 2019, please find enclosed herewith the Statement of deviation(s) or variation(s) for the quarter ended December 31, 2022, as reviewed by the Audit Committee at its meeting held on February 08, 2023.08-02-2023
Windlas Biotech Ltd - 543329 - Submission Of Details Of Extinguishment Pursuant To Provisions Of Regulation 21 Read With Regulation 11 Of The SEBI (Buy-Back Of Securities) Regulations, 2018
pursuant to the provisions of Regulation 21 read with Regulation 11 of the Buy-back Regulations, the Company has completed the extinguishment of 26,484 (Twenty Six Thousand Four Hundred and Eighty Four) equity shares bought back under the Buy-back during the period from January 27, 2023 till February 03, 2023. In connection with the same, we are submitting herewith details of extinguishment along with the debit confirmation letter received from the Central Depository Services Limited and Certificate of Extinguishment for your records08-02-2023
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Monitoring Agency Report dated February 02, 2023 in respect of utilization of proceeds of IPO for the quarter ended December 31, 202208-02-2023
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
Submission of daily report in accordance with Regulation 18(i) of the SEBI (Buy-back of Securities) Regulations, 201808-02-2023
Windlas Biotech Ltd - 543329 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
press release on un-audited Standalone and Consolidated Financial Results for the Quarter and nine months ended December 31, 202208-02-2023